Similar articles for PMID: 17060931

Year	Number of Results
1992	1
1994	1
2001	2
2002	3
2003	1
2004	2
2005	2
2006	4
2007	4
2008	2
2009	5
2010	6
2011	13
2012	8
2013	13
2014	8
2015	12
2016	10
2017	5
2018	3
2019	7
2020	5
2021	2
2022	2
2024	0

1

Activated c-SRC in ductal carcinoma in situ correlates with high tumour grade, high proliferation and HER2 positivity.

Wilson GR, Cramer A, Welman A, Knox F, Swindell R, Kawakatsu H, Clarke RB, Dive C, Bundred NJ. Wilson GR, et al. Br J Cancer. 2006 Nov 20;95(10):1410-4. doi: 10.1038/sj.bjc.6603444. Epub 2006 Oct 24. Br J Cancer. 2006. PMID: 17060931 Free PMC article.

2

Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situ.

Curigliano G, Disalvatore D, Esposito A, Pruneri G, Lazzeroni M, Guerrieri-Gonzaga A, Luini A, Orecchia R, Goldhirsch A, Rotmensz N, Bonanni B, Viale G. Curigliano G, et al. Ann Oncol. 2015 Apr;26(4):682-687. doi: 10.1093/annonc/mdv013. Epub 2015 Jan 18. Ann Oncol. 2015. PMID: 25600567 Free article. Clinical Trial.

3

Absence of HER4 expression predicts recurrence of ductal carcinoma in situ of the breast.

Barnes NL, Khavari S, Boland GP, Cramer A, Knox WF, Bundred NJ. Barnes NL, et al. Clin Cancer Res. 2005 Mar 15;11(6):2163-8. doi: 10.1158/1078-0432.CCR-04-1633. Clin Cancer Res. 2005. PMID: 15788662

4

Is there a low-grade precursor pathway in breast cancer?

King TA, Sakr RA, Muhsen S, Andrade VP, Giri D, Van Zee KJ, Morrow M. King TA, et al. Ann Surg Oncol. 2012 Apr;19(4):1115-21. doi: 10.1245/s10434-011-2053-0. Epub 2011 Sep 21. Ann Surg Oncol. 2012. PMID: 21935747

5

Nudix-type motif 2 in human breast carcinoma: a potent prognostic factor associated with cell proliferation.

Oka K, Suzuki T, Onodera Y, Miki Y, Takagi K, Nagasaki S, Akahira J, Ishida T, Watanabe M, Hirakawa H, Ohuchi N, Sasano H. Oka K, et al. Int J Cancer. 2011 Apr 15;128(8):1770-82. doi: 10.1002/ijc.25505. Int J Cancer. 2011. PMID: 20533549 Free article.

6

Aurora Kinase A Is an Independent Predictor of Invasive Recurrence in Breast Ductal Carcinoma in situ.

Miligy IM, Toss MS, Gorringe KL, Ellis IO, Green AR, Rakha EA. Miligy IM, et al. Pathobiology. 2022;89(6):382-392. doi: 10.1159/000522244. Epub 2022 May 9. Pathobiology. 2022. PMID: 35533650 Free article.

7

Geometric characteristics of collagen have independent prognostic significance in breast ductal carcinoma in situ: an image analysis study.

Toss MS, Miligy IM, Gorringe KL, AlKawaz A, Mittal K, Aneja R, Ellis IO, Green AR, Roxanis I, Rakha EA. Toss MS, et al. Mod Pathol. 2019 Oct;32(10):1473-1485. doi: 10.1038/s41379-019-0296-7. Epub 2019 Jun 7. Mod Pathol. 2019. PMID: 31175326 Free article.

8

Biofunctional characteristics of in situ and invasive breast carcinoma.

Bravaccini S, Granato AM, Medri L, Foca F, Falcini F, Zoli W, Ricci M, Lanzanova G, Masalu N, Serra L, Buggi F, Folli S, Silvestrini R, Amadori D. Bravaccini S, et al. Cell Oncol (Dordr). 2013 Jul;36(4):303-10. doi: 10.1007/s13402-013-0135-7. Epub 2013 Jun 27. Cell Oncol (Dordr). 2013. PMID: 23807750

9

Differential Gene Expression in Ductal Carcinoma In Situ of the Breast Based on ERBB2 Status.

Agosto-Arroyo E, Isayeva T, Wei S, Almeida JS, Harada S. Agosto-Arroyo E, et al. Cancer Control. 2017 Jan;24(1):102-110. doi: 10.1177/107327481702400117. Cancer Control. 2017. PMID: 28178722 Free article.

10

[Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].

Yang M, Xu SP, Ao QL. Yang M, et al. Zhonghua Bing Li Xue Za Zhi. 2013 Apr;42(4):257-61. doi: 10.3760/cma.j.issn.0529-5807.2013.04.010. Zhonghua Bing Li Xue Za Zhi. 2013. PMID: 23928534 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

100 results

Results by year